146 related articles for article (PubMed ID: 17540969)
21. Progression of asymptomatic carotid stenosis despite optimal medical therapy.
Conrad MF; Boulom V; Mukhopadhyay S; Garg A; Patel VI; Cambria RP
J Vasc Surg; 2013 Jul; 58(1):128-35.e1. PubMed ID: 23806255
[TBL] [Abstract][Full Text] [Related]
22. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis.
Famakin BM; Chimowitz MI; Lynn MJ; Stern BJ; George MG;
Stroke; 2009 Jun; 40(6):1999-2003. PubMed ID: 19407228
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
[TBL] [Abstract][Full Text] [Related]
24. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis.
Qureshi AI; Hussein HM; El-Gengaihy A; Abdelmoula M; K Suri MF
Neurosurgery; 2008 May; 62(5):1053-60; discussion 1060-2. PubMed ID: 18580803
[TBL] [Abstract][Full Text] [Related]
25. Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?
Chaturvedi S; Turan TN; Lynn MJ; Derdeyn CP; Fiorella D; Janis LS; Chimowitz MI;
Stroke; 2015 Sep; 46(9):2562-7. PubMed ID: 26251251
[TBL] [Abstract][Full Text] [Related]
26. Early aggressive medical management for patients with symptomatic intracranial stenosis.
Nahab F; Kingston C; Frankel MR; Dion JE; Cawley CM; Mitchell B; Hammonds LP; Ayala L; Tong FC
J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):87-91. PubMed ID: 21795066
[TBL] [Abstract][Full Text] [Related]
27. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
Ovbiagele B; Saver JL; Lynn MJ; Chimowitz M;
Neurology; 2006 May; 66(9):1344-9. PubMed ID: 16682665
[TBL] [Abstract][Full Text] [Related]
28. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
29. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Amarenco P; Davis S; Jones EF; Cohen AA; Heiss WD; Kaste M; Laouénan C; Young D; Macleod M; Donnan GA;
Stroke; 2014 May; 45(5):1248-57. PubMed ID: 24699050
[TBL] [Abstract][Full Text] [Related]
30. Clinical and anatomic outcomes after carotid endarterectomy.
Kang J; Conrad MF; Patel VI; Mukhopadhyay S; Garg A; Cambria MR; LaMuraglia GM; Cambria RP
J Vasc Surg; 2014 Apr; 59(4):944-9. PubMed ID: 24661892
[TBL] [Abstract][Full Text] [Related]
31. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
[TBL] [Abstract][Full Text] [Related]
32. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
[TBL] [Abstract][Full Text] [Related]
33. Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM).
Sullivan RM; Zhang J; Zamba G; Lip GY; Olshansky B
Am J Cardiol; 2012 Dec; 110(12):1799-802. PubMed ID: 22995971
[TBL] [Abstract][Full Text] [Related]
34. Use of secondary medical prophylaxis and clinical outcome among patients with ischemic stroke: a nationwide follow-up study.
Palnum KH; Mehnert F; Andersen G; Ingeman A; Krog BR; Bartels PD; Johnsen SP
Stroke; 2012 Mar; 43(3):802-7. PubMed ID: 22207506
[TBL] [Abstract][Full Text] [Related]
35. Predictors of recurrent stroke in patients with symptomatic intracranial arterial stenosis.
Jung JM; Kang DW; Yu KH; Koo JS; Lee JH; Park JM; Hong KS; Cho YJ; Kim JS; Kwon SU;
Stroke; 2012 Oct; 43(10):2785-7. PubMed ID: 22910894
[TBL] [Abstract][Full Text] [Related]
36. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
37. Sex differences and similarities in the management and outcome of stroke patients.
Holroyd-Leduc JM; Kapral MK; Austin PC; Tu JV
Stroke; 2000 Aug; 31(8):1833-7. PubMed ID: 10926943
[TBL] [Abstract][Full Text] [Related]
38. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
[TBL] [Abstract][Full Text] [Related]
39. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
[TBL] [Abstract][Full Text] [Related]
40. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
